

SEARCH
QUICKLINKS AND VIEW OPITONS
People blood sugar levels of 100 mg/dL were 2.4 times more likely to die in 2 years than w/67 mg/dL
Posted by .(JavaScript must be enabled to view this email address)
Monday, October 17, 2011 11:27 am Email this article
People with cardiovascular disease whose blood sugar levels were at the top of the normal range, being 100 mg per deciliter, were 2.4 times more likely to die over the next two (2) years than those with blood sugar levels in the bottom of the normal range, being 67 mg per deciliter according to a analysis by UCLA statistician, Sidney Port, PhD. Risk of Death with Low Normal Blood Sugar
Risk of Death with Low Normal Blood Sugar of 67 mg/dL : 3% died over next 2 years
2.99% of people with cardiovascular disease with low normal blood sugar levels of 67 mg/dL died during the next two-years.
Risk of Death with High Normal Blood Sugar
Risk of Death with High Normal Blood Sugar of 100 mg/dL : 7% died over next 2 years
7.23% of people with cardiovascular disease with high normal blood sugar levels of 100 mg/dL died during the next two-years.
High Normal Blood Sugar vs Low Normal Blood Sugar
Risk of Death was 2.4 times higher in those with Blood Sugar of 100 mg/dL vs 67 mg/dL
This means that people with cardiovascular disease were 2.4 times more likely to die if their blood sugar levels were high-normal of 100 mg/dL compared with those who had low-normal blood sugar levels of 67 mg/dL—7.23% divided by 2.99% equals 2.4 times greater risk.
Conclusion
Conclusion: Blood sugar levels are a strong independent predictor of 2-year all-cause mortality in those with cardiovascular disease
“There were steep graded relations of 2-year all-cause, [ cardiovascular mortality ], and [ non-cardiovascular mortality / all-cause mortality ] to [ blood sugar levels ] throughout the normal and subdiabetic range with no evidence of a lower threshold,” Sid Port noted.
“Blood glucose, even within the normal range, is a strong independent predictor of 2-year all-cause, [ cardiovascular mortality ], and [ non-cardiovascular mortality ] in nondiabetic subjects with [ cardiovascular disease ] and therefore of prognostic significance for these high-risk patients,” Port concluded.
Comment #1
Comment : This does NOT mean that oral diabetes drugs will lower your risk of death
Comment #1: This does NOT mean that oral diabetes drugs will lower your risk of death.
Julian Whitaker, MD uses NO oral diabetes drugs
Julian Whitaker, MD uses NO oral diabetes drugs in Type 2 diabetics
Julian Whitaker, MD from the Whitaker Wellness in Newport Beach, California uses NO oral diabetes drugs in Type 2 diabetics.
Dr. Whitaker is the author of “Reversing Diabetes”.
I encourage you to read it to find out how to control your diabetes WITHOUT drugs… however, metformin taken ALONE WITH NO OTHER DIABETES DRUGS might be an exception.
Comment #2
Comment #2: I have become much more anti-drug, but metformin taken ALONE WITH NO OTHER DIABETES DRUGS may be an exception
I have become much more anti-drug in the last 4 years, since the beginning of 2008, watching the way prescription drugs destroyed my mother’s life and her doctors seemed oblivious to this—she just died Sept 13, 2011 and my father died Sept 1, 2011—however, metformin taken ALONE WITH NO OTHER DIABETES DRUGS might be an exception.
Ward Dean, MD, an anti-aging doctor recommends metformin to his patients over 40, and has said that Russian gerontologist Vladimir Dilman, MD, PhD said that phenformin, metformin’s stronger cousin, “did everything”, and extended the lifespan of animals.
See the article here:
I don’t like any of the other diabetes drugs at this point.
Also see the following articles:
- Intensive glucose-lowering treatment resulted in 4% HIGHER risk of death according to meta-analysis
- Intensive glucose-lowering treatment INCREASED the risk of congestive heart failure by 47%
- Metformin plus a sulphonylurea increased the risk of death 96% over 10.7 years in Type 2 diabetics
REFERENCE
Port S, Goodarzi M, Boyle N, Jennrich R. Blood glucose: A strong risk factor for mortality in nondiabetic patients with cardiovascular disease. Am Heart J. 2005 Aug, 150(2):209-14.
AUTHOR’S CONTACT INFORMATION
Sidney C. Port, Ph.D.
Mathematics Department
University of California, Los Angeles (UCLA)
Los Angeles, CA 90095-1555
(310) 825 2207 phone
(310) 825 4701 phone
(310) 206-6673 fax
.(JavaScript must be enabled to view this email address)
.(JavaScript must be enabled to view this email address)
Articles on the same subject can be found here:
COMMENTS
Please feel free to share your comments about this article.
© Copyright 2003-2021 - Larry Hobbs - All Rights Reserved.